AIOCD demands urgent relief for small chemists amidst GST 2.0 transition: Peethaambaran Kunnathoor, Chennai Wednesday, ...
Kedrion Biopharma receives US FDA approval for Qivigy to treat adults with primary humoral immunodeficiency: Barga, Italy Wednesday, October 1, 2025, 10:00 Hrs [IST] Kedrion Bioph ...
CollPlant announces positive results from non-clinical studies of its photocurable regenerative dermal and soft tissue filler: Rehovot, Israel Wednesday, October 1, 2025, 18:00 Hr ...
Japan’s MHLW grants orphan drug designation to Vicore Pharma’s buloxibutid to treat idiopathic pulmonary fibrosis: Stockholm Wednesday, October 1, 2025, 17:00 Hrs [IST] Vicore ...
Data show Roche’s sixth-generation Troponin T test offers a new level of accuracy critical for diagnosing heart attacks: Basel Wednesday, October 1, 2025, 11:00 Hrs [IST] Roche ...
Pfizer reaches landmark agreement with US government to lower drug costs for American patients: New York Wednesday, October 1, 2025, 16:30 Hrs [IST] Pfizer Inc. announced a histor ...
Cardinal Health to expand pharmaceutical distribution network with new Indianapolis facility: Dublin Wednesday, October 1, 2025, 16:00 Hrs [IST] Cardinal Health, a distributor of ...
Nonprofit digital health organization Data4Life and South Korea’s leading federated research platform EvidNet announced a strategic partnership to co-develop a global infrastructure for federated real ...
Symbiosis expands sterile manufacturing capacity with fill/finish line qualification: Stirling, UK Wednesday, October 1, 2025, 14:00 Hrs [IST] Symbiosis Pharmaceutical Services (S ...
Child deaths reported in MP allegedly due to contaminated cough syrup, experts initiate probe: Our Bureau, New Delhi Wednesday, October 1, 2025, 12:45 Hrs [IST] At least six child ...
Epigenica AB, the leader in epigenomic innovation, announces the launch of the EpiFinder GenomePro, a cutting-edge platform for advanced epigenomic research. The EpiFinder GenomePro enables ...
Vector Consulting Group sees US 100% tariffs to dent oral solids and become commercially unviable: Nandita Vijayasimha, Bengaluru Wednesday, October 1, 2025, 08:00 Hrs [IST] If In ...